JP2025163128A5 - - Google Patents

Info

Publication number
JP2025163128A5
JP2025163128A5 JP2025128256A JP2025128256A JP2025163128A5 JP 2025163128 A5 JP2025163128 A5 JP 2025163128A5 JP 2025128256 A JP2025128256 A JP 2025128256A JP 2025128256 A JP2025128256 A JP 2025128256A JP 2025163128 A5 JP2025163128 A5 JP 2025163128A5
Authority
JP
Japan
Prior art keywords
branched
substituted
unsubstituted
straight
reducing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2025128256A
Other languages
English (en)
Japanese (ja)
Other versions
JP7904373B2 (ja
JP2025163128A (ja
Filing date
Publication date
Priority claimed from PCT/IL2020/050524 external-priority patent/WO2020230134A1/en
Application filed filed Critical
Publication of JP2025163128A publication Critical patent/JP2025163128A/ja
Publication of JP2025163128A5 publication Critical patent/JP2025163128A5/ja
Application granted granted Critical
Publication of JP7904373B2 publication Critical patent/JP7904373B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2025128256A 2019-05-14 2025-07-31 イミダゾール3-オキシド誘導体系acss2阻害剤及びその使用方法 Active JP7904373B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962847348P 2019-05-14 2019-05-14
PCT/IL2020/050524 WO2020230134A1 (en) 2019-05-14 2020-05-14 Acss2 inhibitors and methods of use thereof
ILPCT/IL2020/050524 2020-05-14
JP2022568774A JP7723011B2 (ja) 2019-05-14 2021-05-12 イミダゾール3-オキシド誘導体系acss2阻害剤及びその使用方法
PCT/IL2021/050541 WO2021229571A1 (en) 2019-05-14 2021-05-12 Imidazole 3-oxide derivative based acss2 inhibitors and methods of use thereof

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2022568774A Division JP7723011B2 (ja) 2019-05-14 2021-05-12 イミダゾール3-オキシド誘導体系acss2阻害剤及びその使用方法

Publications (3)

Publication Number Publication Date
JP2025163128A JP2025163128A (ja) 2025-10-28
JP2025163128A5 true JP2025163128A5 (cg-RX-API-DMAC7.html) 2025-11-06
JP7904373B2 JP7904373B2 (ja) 2026-08-12

Family

ID=73288933

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2021567836A Pending JP2022532718A (ja) 2019-05-14 2020-05-14 Acss2阻害剤およびその使用方法
JP2021567839A Pending JP2022532719A (ja) 2019-05-14 2020-05-14 Acss2阻害剤およびその使用方法
JP2022568774A Active JP7723011B2 (ja) 2019-05-14 2021-05-12 イミダゾール3-オキシド誘導体系acss2阻害剤及びその使用方法
JP2025128256A Active JP7904373B2 (ja) 2019-05-14 2025-07-31 イミダゾール3-オキシド誘導体系acss2阻害剤及びその使用方法

Family Applications Before (3)

Application Number Title Priority Date Filing Date
JP2021567836A Pending JP2022532718A (ja) 2019-05-14 2020-05-14 Acss2阻害剤およびその使用方法
JP2021567839A Pending JP2022532719A (ja) 2019-05-14 2020-05-14 Acss2阻害剤およびその使用方法
JP2022568774A Active JP7723011B2 (ja) 2019-05-14 2021-05-12 イミダゾール3-オキシド誘導体系acss2阻害剤及びその使用方法

Country Status (12)

Country Link
US (3) US12441689B2 (cg-RX-API-DMAC7.html)
EP (3) EP3983386A4 (cg-RX-API-DMAC7.html)
JP (4) JP2022532718A (cg-RX-API-DMAC7.html)
KR (3) KR20220024014A (cg-RX-API-DMAC7.html)
CN (3) CN114008025A (cg-RX-API-DMAC7.html)
AU (3) AU2020273727A1 (cg-RX-API-DMAC7.html)
BR (2) BR112021022977A2 (cg-RX-API-DMAC7.html)
CA (3) CA3136083A1 (cg-RX-API-DMAC7.html)
IL (3) IL297883A (cg-RX-API-DMAC7.html)
MX (3) MX2021013786A (cg-RX-API-DMAC7.html)
SG (2) SG11202112277PA (cg-RX-API-DMAC7.html)
WO (3) WO2020230134A1 (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12133852B2 (en) 2017-11-15 2024-11-05 Epivario, Inc. ACSS2 inhibitors and methods of use thereof
US11795160B2 (en) 2019-02-22 2023-10-24 Insilico Medicine Ip Limited Kinase inhibitors
EP3983386A4 (en) * 2019-05-14 2023-01-11 Metabomed Ltd ACSS2 INHIBITORS AND METHODS OF USE THEREOF
PH12022551379A1 (en) 2019-12-06 2023-05-03 Vertex Pharma Substituted tetrahydrofurans as modulators of sodium channels
CN112480085B (zh) * 2020-12-17 2022-10-25 上海英诺富成生物科技有限公司 一种化合物或其药学上可接受的盐、异构体、前药、多晶型物或溶剂化物
AU2022225035A1 (en) 2021-02-24 2023-08-31 Insilico Medicine Ip Limited Analogs for the treatment of disease
SI4347031T1 (sl) 2021-06-04 2026-01-30 Vertex Pharmaceuticals Incorporated N-(hidroksialkil (hetero)aril) tetrahidrofuran karboksamidi kot modulatorji natrijevih kanalčkov
CN114044754A (zh) * 2021-11-23 2022-02-15 贵州大学 一类5-三氟甲基-4-吡唑衍生物的制备方法及其在抑制肿瘤细胞上的应用
CN114716380B (zh) * 2022-04-01 2024-06-21 新乡医学院 一种相转移催化的4-取代吡唑酮类化合物不对称氟化方法
US20260137687A1 (en) * 2022-08-24 2026-05-21 The Regents Of The University Of California GTPase INHIBITORS AND USES THEREOF
CN116808042A (zh) * 2023-08-08 2023-09-29 江苏省人民医院(南京医科大学第一附属医院) 乙酰辅酶a合成酶2抑制剂在治疗胰腺神经内分泌肿瘤中的应用
CN118344267A (zh) * 2024-04-17 2024-07-16 广东广康生化科技股份有限公司 一种联苯肼酯高效合成新方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE140966C (cg-RX-API-DMAC7.html)
DE2324893A1 (de) 1973-05-17 1974-12-12 Hoechst Ag 1-hydroxy-imidazole und verfahren zu ihrer herstellung
US3905997A (en) 1974-06-21 1975-09-16 Warner Lambert Co 3-Aryl-5-oxo-2-pyrazoline-4-carboxanilides and process therefor
US4207317A (en) 1978-03-13 1980-06-10 Ciba-Geigy Corporation 1-Aryl-4-carbamoyl-pyrazolin-5-ones
DD140966A1 (de) * 1978-12-28 1980-04-09 Doerthe Creuzburg Mittel zur regulierung des pflanzenwachstums
JPH11291635A (ja) 1998-04-06 1999-10-26 Mitsubishi Paper Mills Ltd 感熱記録材料
DE69926148D1 (en) * 1998-11-09 2005-08-18 Black James Foundation Gastrin und cholecystokinin rezeptor ligande
AR034897A1 (es) 2001-08-07 2004-03-24 Hoffmann La Roche Derivados n-monoacilados de o-fenilendiaminas, sus analogos heterociclicos de seis miembros y su uso como agentes farmaceuticos
CA2465978C (en) * 2001-09-14 2015-04-07 Soon Hyung Woo Inhibitors of histone deacetylase
JP4988591B2 (ja) * 2004-12-17 2012-08-01 イーライ リリー アンド カンパニー 新規なmch受容体アンタゴニスト
WO2007026215A1 (en) * 2005-08-29 2007-03-08 Glenmark Pharmaceuticals S.A. Pyrazole derivatives as cannabinoid receptor ligands, pharmaceutical compositions containing? them, and processes for their preparation
JP2013526540A (ja) * 2010-05-12 2013-06-24 バーテックス ファーマシューティカルズ インコーポレイテッド Atrキナーゼ阻害剤として有用な化合物
US9073911B2 (en) * 2011-06-09 2015-07-07 Hoffmann-La Roche Inc. Pyrazole derivatives
AU2012355624A1 (en) * 2011-12-23 2014-07-17 Novartis Ag Compounds for inhibiting the interaction of BCL2 with binding partners
WO2013159224A1 (en) 2012-04-25 2013-10-31 University Of Manitoba 2-carbamo(thio)yl-1,3- dioxopropyl derivatives in cancer therapy
WO2015175845A1 (en) 2014-05-15 2015-11-19 Peloton Therapeutics, Inc. Benzimidazole derivatives and uses thereof
ES2995198T3 (en) 2016-01-05 2025-02-07 Incyte Corp Pyridine compounds as pi3k-gamma inhibitors
WO2019036562A1 (en) * 2017-08-18 2019-02-21 Saint Louis University ERR INVERSE AGONISTS
CN111629787A (zh) * 2017-09-26 2020-09-04 宾夕法尼亚大学理事会 用于抑制acss2的组合物和方法
CA2984073A1 (en) 2017-10-27 2019-04-27 Nuchem Therapeutics Inc. Inhibitors of polynucleotide repeat-associated rna foci and uses thereof
EP3710430B9 (en) 2017-11-15 2024-10-30 Metabomed Ltd Acss2 inhibitors and methods of use thereof
EP3983386A4 (en) 2019-05-14 2023-01-11 Metabomed Ltd ACSS2 INHIBITORS AND METHODS OF USE THEREOF

Similar Documents

Publication Publication Date Title
IL297883A (en) acss2 inhibitors based on imidazole 3-oxide derivatives and methods for their use
RU2095356C1 (ru) Способ получения производных таксана и производные таксана
IL274504B2 (en) Acss2 inhibitors and methods of use thereof
JP7811768B2 (ja) ピロール化合物
JP2011509309A5 (cg-RX-API-DMAC7.html)
JPH02212435A (ja) 哺乳動物における内毒素シヨツクの治療方法
JP2007508238A5 (cg-RX-API-DMAC7.html)
RU2002117422A (ru) 4-пиримидинил-N-ацил-L-фенилаланины
JP2017534657A (ja) 新型シチジン誘導体およびその適用
JP2002529465A5 (cg-RX-API-DMAC7.html)
EP2123620A1 (en) {F-19}-labeled L-Glutamic acid and L-Glutamine derivative (III), use thereof and method for obtaining them
JP2018526448A (ja) 一酸化窒素を放出可能なプロドラッグ分子
EP2669280B1 (en) Bicyclic compound and use thereof for medical purposes
JP2022546711A5 (cg-RX-API-DMAC7.html)
ES2945062T3 (es) Derivados de ácido barbitúrico novedosos, su preparación y uso de los mismos como inhibidores de la transmigración de leucocitos y para el tratamiento de enfermedades inflamatorias, enfermedades autoinmunitarias y cáncer
US12473305B2 (en) Pyrazole boronic acid compound, pharmaceutical composition containing same, and uses thereof
JP2017137323A (ja) 新規抗がん剤
JP2021532158A5 (cg-RX-API-DMAC7.html)
JP2026503618A5 (cg-RX-API-DMAC7.html)
JP2020518649A5 (cg-RX-API-DMAC7.html)
RU2011129771A (ru) Противораковые соединения
JP2022523792A5 (cg-RX-API-DMAC7.html)
RU2025115630A (ru) Производные тиадиазолила в качестве ингибиторов днк-полимеразы тета и их применение
US5599825A (en) Water-soluble methine compound and pharmaceutical composition for treatment of cancer comprising the same
JP6542799B2 (ja) 新規peg誘導体